Giel Hendriks

Giel Hendriks is the CEO and Executive Director of Toxys, a company that specializes in developing reporter systems to study the mode of action of genotoxic chemicals. Prior to their current position, Hendriks worked as a Senior Scientist at the Leiden University Medical Center from August 2004 to April 2016. There, they were responsible for combining whole genome transcription profiling with advanced genome editing tools and stem cell expertise to develop various in vitro reporter systems.

Hendriks has been instrumental in developing the ToxTracker assay, a stem cell-based reporter assay that provides mechanistic insight into the mode of action of genotoxic compounds. The ToxTracker assay has been extensively validated using various libraries of reference compounds and is currently used for the identification of different potential carcinogenic properties of compounds during chemical human health hazard assessment.

Giel Hendriks has a Msc in Molecular Cell Biology from Utrecht University.

Marianne Brummelkamp - Office Manager, Torben Osterlund - Chief Scientific Officer, and Remco Derr - COO report to Giel Hendriks.